Heteroaryl urea neuropeptide Y Y5 receptor antagonists
US6946476B2 · kind B2 · utility
7Cited by
2References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2002 |
| Grant date | Sep 20, 2005 |
| Priority date | — |
| Expiry date | Jun 30, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds represented by the structural Formula I: or a pharmaceutically acceptable salt thereof, which are useful for the treatment of metabolic and eating disorders such as obesity and hyperphagia, and for the treatment of diabetes and associated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.